Skip to main navigation Skip to search Skip to main content

Timing of response with venetoclax combination treatment in patients with newly diagnosed acute myeloid leukemia

  • Brian A. Jonas
  • , Andrew H. Wei
  • , Christian Recher
  • , Courtney D. DiNardo
  • , Jun Ho Jang
  • , Keith Pratz
  • , Panayiotis Panayiotidis
  • , Pau Montesinos
  • , Su Peng Yeh
  • , Vladimir Ivanov
  • , Walter Fiedler
  • , Takahiro Yamauchi
  • , Yinghui Duan
  • , Wellington Mendes
  • , Jalaja Potluri
  • , Björn Tews
  • , Yishai Ofran
  • University of California at Davis
  • Alfred Health
  • CHU de Toulouse
  • Université Paul-Sabatier
  • University of Texas MD Anderson Cancer Center
  • Sungkyunkwan University
  • University of Pennsylvania
  • National and Kapodistrian University of Athens
  • Hospital Universitario La Fe
  • China Medical University Taichung
  • Almazov National Medical Research Centre
  • University of Hamburg
  • University of Fukui
  • AbbVie
  • Hebrew University of Jerusalem

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)E299-E303
JournalAmerican Journal of Hematology
Volume97
Issue number8
DOIs
StatePublished - Aug 2022
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this